AbCellera to Participate at Upcoming Investor Conferences in March
AbCellera (ABCL) has announced its participation in two major investor conferences in March. The company will attend the 45th Annual TD Cowen Health Care Conference scheduled for March 3-5, and the KeyBanc Capital Markets Healthcare Forum taking place March 18-19. Interested parties can find more details on AbCellera's Investor Relations website.
AbCellera (ABCL) ha annunciato la sua partecipazione a due importanti conferenze per investitori a marzo. L'azienda parteciperà al 45° Annuale TD Cowen Health Care Conference, in programma dal 3 al 5 marzo, e al KeyBanc Capital Markets Healthcare Forum, che si svolgerà dal 18 al 19 marzo. Le parti interessate possono trovare ulteriori dettagli sul sito delle Relazioni con gli Investitori di AbCellera.
AbCellera (ABCL) ha anunciado su participación en dos importantes conferencias de inversores en marzo. La compañía asistirá a la 45ª Conferencia Anual de Salud de TD Cowen, programada del 3 al 5 de marzo, y al Foro de Salud de KeyBanc Capital Markets, que tendrá lugar del 18 al 19 de marzo. Las partes interesadas pueden encontrar más detalles en el sitio web de Relaciones con Inversores de AbCellera.
AbCellera (ABCL)는 3월에 열리는 두 개의 주요 투자자 회의에 참석한다고 발표했습니다. 이 회사는 3월 3일부터 5일까지 예정된 제45회 TD Cowen 의료 회의와 3월 18일부터 19일까지 열리는 KeyBanc 캐피털 마켓 의료 포럼에 참석할 예정입니다. 관심 있는 분들은 AbCellera의 투자자 관계 웹사이트에서 자세한 정보를 찾을 수 있습니다.
AbCellera (ABCL) a annoncé sa participation à deux grandes conférences pour investisseurs en mars. La société assistera à la 45e Conférence Annuelle TD Cowen sur les Soins de Santé prévue du 3 au 5 mars, ainsi qu'au Forum sur les Soins de Santé de KeyBanc Capital Markets qui se déroulera du 18 au 19 mars. Les parties intéressées peuvent trouver plus de détails sur le site des Relations avec les Investisseurs d'AbCellera.
AbCellera (ABCL) hat seine Teilnahme an zwei wichtigen Investorenkonferenzen im März bekannt gegeben. Das Unternehmen wird an der 45. jährlichen TD Cowen Gesundheitskonferenz teilnehmen, die vom 3. bis 5. März stattfindet, und am Healthcare Forum von KeyBanc Capital Markets, das am 18. und 19. März stattfindet. Interessierte Personen finden weitere Informationen auf der Website der Investor Relations von AbCellera.
- None.
- None.
- 45th Annual TD Cowen Health Care Conference, March 3-5
- KeyBanc Capital Markets Healthcare Forum, March 18-19
Visit AbCellera's Investor Relations website for additional information.
About AbCellera Biologics Inc.
AbCellera (Nasdaq: ABCL) discovers and develops antibody medicines for indications across therapeutic areas including cancer, metabolic and endocrine conditions, and autoimmune disorders. AbCellera’s engine integrates technology, data science, infrastructure, and interdisciplinary teams to solve the most challenging antibody discovery problems. AbCellera is focused on advancing an internal pipeline of first-in-class and best-in-class programs and collaborating on innovative drug development programs with partners. For more information, please visit www.abcellera.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250211013862/en/
Inquiries
Media: Tiffany Chiu; media@abcellera.com, +1(604)724-1242
Business Development: Murray McCutcheon, Ph.D.; partnering@abcellera.com, +1(604)559-9005
Investor Relations: Peter Ahn; ir@abcellera.com, +1(778)729-9116
Source: AbCellera Biologics Inc.
FAQ
Which investor conferences will AbCellera (ABCL) attend in March 2024?
When is AbCellera (ABCL) presenting at the TD Cowen Health Care Conference?
What is the date for AbCellera's (ABCL) participation in the KeyBanc Healthcare Forum?
Where can investors find more information about AbCellera's (ABCL) conference presentations?
